Tagged as: preliminary injunction

Novartis Sues Janssen Over Tremfya® False Advertising

On March 1, 2019, Novartis sued Johnson & Johnson subsidiary Janssen for allegedly presenting false and misleading data about its plaque psoriasis drug Tremfya® (guselkumab).  Novartis alleges that its Cosentyx® (secukinumab) drug, which is also indicated for the treatment of plaque psoriasis, competes with Tremfya®.  Novartis claims that Janssen failed to…

Read More